At Adalvo, there are no half measures – we are always on target. When your mission is to be faster and stronger than your competitors, you need a winning team driving your vision forward. You need people that has the industry know how and internal capabilities that align with your business goals. You need a team that has a passion for relentless commitment to you.

Our team is your team

Anil is the CEO at Adalvo, CCO of Alvotech and Chairman of the Board at Arphio. Anil comes with an impressive track record as a CEO, P&L owner, commercial operations professional and expert negotiator, completing countless license, acquisition, supply, distribution, and sales and marketing agreements, worth >$25B. Over the course of his 15-year career in the pharmaceutical industry, Anil developed an extensive network and deep expertise in Commercial Operations, BD and M&A. Anil plays an integral role in building and establishing Adalvo as one of the leading B2B companies in Europe.

Anil previously served as the Head of Global Licensing for HELM AG where he managed all partnerships for small molecules in addition to biosimilars through a joint venture with Gedeon Richter, resulting in the most successful commercial performance in the company’s 40-year history. He also held positions of increasing responsibility at Abdi Ibrahim, in various regions and functions, eventually heading all international market operations where he developed and led the successful execution of a global market entry strategy including more than 30 new markets. He began his career at Sanofi as a medical rep and transitioned to business development.

Anil holds an MBA from the Vienna University of Economics and Business and a Master of Marketing Management from Galatasaray University. He completed a Bachelor of Engineering with a double major in Mathematics and Computer Engineering, graduating with honors. He has continued honing his skillset through various executive education programs at Harvard and INSEAD.

Anil was recognized “Leader of the Year” at the 2021 Global Generics and Biosimilars Awards.

Anil Okay

Martina is leading the Scientific Affairs teams for Adalvo. She brings more than 20 years of experience within the pharmaceutical industry. She has been working across global regulatory setup for over 15 years. Leading teams in all continents, Martina successfully spearheaded several thousands of MA strategies including a number of proprietary, 505b2/hybrid and complex products.

During her career, she was able to bring innovative and proprietary products to full regulatory approval earlier than those products could be granted an EU regulatory approval.

Martina Feitzinger

Arni Baldursson

Vitalii Slobodian

Nil Cinar is leading the Strategic Partnership team. She holds overall over 17 years of experience in the pharmaceutical industry. During her career, Nil has taken leadership roles in various departments of multinational pharmaceutical companies, and carried out responsibilities for commercial operations, business development, establishing and expanding geographical presence beyond the existing markets, and expanding company product pipelines, in several therapeutic areas.

Nil brings extensive knowledge and experience in various business deal models of Licensing, Co-development, M&A, fee-for-service, and possess a worldwide pharmaceutical business network. Nil has secured partnerships throughout all continents from USA, to EU and to China, and expanded company pipeline significantly with new products additions, including Proprietary and 505b2 programs, small molecules and complex injectables as well. 

Nil holds Bachelor of Science and Master of Science degrees in Chemical Engineering, and has been certified through INSEAD management program. 

Nil Cinar

Toni is leading the Intellectual Property team at Adalvo. He has more than 20 years of experience in different pharmaceutical companies where he has been involved in developing and implementing complex patent and data exclusivity litigation strategies for several generics and added value products, including leading parallel litigation cases in multiple European countries.   He also has experience in patent and trademark prosecution.

Toni qualified as European Patent Attorney in 2010 and holds a PhD in Organic Chemistry.  

Toni Santamaria

Martin Paunov is leading the Alliance Management & Commercial Execution team at Adalvo. Martin has over 10 years’ experience within the pharmaceutical industry, leading various activities such as supply chain setup, procurement, new product launches globally including Biosimilars, business development activities,  market development and product lifecycle management. Martin’s is a highly competitive and business oriented individual and his primary interests lie within market development and supply chain optimization. 

Martin Paunov

Istvan is leading the Portfolio function for Adalvo. He brings 15 years of experience in the industry. Throughout his career he has been involved in managing portfolio and product securement for various regional and global companies. His interest lies mainly with complex and orphan products where he brings a solid track record navigating in various commercial regions from Europe to Asia-Pacific. Istvan brings a broad knowledge when it comes to product assessment, market evaluation and competitive intelligence.

Istvan holds an M.sc in Economics and an MBA in Business Management.

Istvan Tisler

Luca is leading the R&D function for Adalvo. He brings 13 years of experience in the industry. Throughout his career he has been involved in the development of generics, 505b2 and brand product for WW market. His interest lies mainly with complex drug product like injectable peptides, implants, extended-release oral dosage forms and topical product. Luca brings a broad knowledge when it comes to technical product assessment, drug product development and registration in market high regulated markets.

Luca holds an Ph.D in Pharmaceutical technology and Biopharmaceutics  

Luca Strusi

Alessandra Ruggiero is leading the Quality team at Adalvo. She bringing with her more than 20 years of hands-on experience in pharmaceutical technical operations and quality with a successful track record of compliance remediation of big manufacturing sites producing injectables. Before joining Adalvo, Alessandra covered different Quality Leadership roles in different pharmaceutical companies like Biosearch manufacturing (Aventis spin off), J&J, Pfizer, Haupt Pharma, Patheon Thermofisher, Kedrion, IBI Farmaceutici, leading more than 30 regulatory inspections from US-FDA, PMDA, ANVISA, EMA, Russian MoH, Turkish MoH. Alessandra started her career in Research & Development at Biosearch manufacturing (merged into Vicuron/Pfizer). Alessandra received a Master Degree in Industrial Chemistry from the University of Federico II Naples, Italy. She is very passionate about pharmaceutical production and is always focused on the quality of our products and patients safety.

Alessandra Ruggiero

Jaime is leading the legal function at Adalvo. Over the course of his 10-year career, Jaime has gained extensive experience in negotiating various agreements  associated with the Pharmaceutical industry. Within Adalvo, Jaime is responsible for drafting and reviewing all types of contracts for pharmaceutical products (such as in/out licensing, co-development and distribution agreements) and providing assistance towards the negotiation process. Jaime plays an important role in contract discussions and has assisted to secure over 100 deals per year for Adalvo since his arrival.  

Before joining Adalvo in 2020, he previously served as Legal Advisor for Accord Healthcare and Intas Pharmaceuticals where he provided legal advice on contractual and corporate matters. He also served as lawyer in PwC and Spanish IP law firm P&T Intellectual Property.

Jaime Isern

Gabi Cassar is leading the Human Resources and Corporate Communications functions at Adalvo, bringing over 10 years of experience within the HR field. Her background and experience comes from   an array of different industries including hospitality, events and pharmaceutical. Gabi is responsible for the strategic development of the human resources function and people strategy. She has extensive experience with employee engagement, compensation and benefits, reward & recognition, professional growth, culture & communications, training and performance management.

Gabi graduated with a Bachelor degree in Psychology and furthered her studies by reading for a MBA, from Henley University. She continued to enhance her knowledge through various education programs related to counselling and digital marketing.

Gabi Cassar

In this pivotal role, Mark oversees all financial operations, drive strategic financial planning, budgeting, and forecasting, and spearhead initiatives to ensure Adalvo’s financial health and sustainable growth. He is also instrumental in managing risk and leading financial strategies aligned with our business objectives.

Mark brings with him an impressive 20-year career spanning both professional services and key industry sectors. At  Deloitte Malta, he dedicated 17 years to managing an extensive portfolio of local and international audit clients across diverse industries. His expertise deepened as he took on senior finance leadership roles at Alvogen and Calamatta Cuschieri Moneybase Plc, where he successfully managed complex corporate structures within shared service environments in highly regulated fields, demonstrating an exceptional ability to drive financial efficiency and compliance.

Known for his passion for people, Mark excels in building high-performing teams and driving change management, ensuring sustainable financial growth and operational efficiency. A Fellow of the Association of Chartered Certified Accountants (FCCA), he brings a wealth of expertise in corporate finance, compliance, and strategic planning, making him a valuable asset in guiding the company's financial future.

Mark Decesare

Frank Fischer serves as Adalvo's VP of Information Technology, spearheading the development and execution of the company's IT strategy. With over 35 years in the IT industry, he brings extensive experience from renowned companies like Microsoft and Google. Frank's diverse technical background, combined with a strong business acumen, makes him a valuable asset for Adalvo. He holds an MSc in IT and an MSc in Business and Organizational Psychology from the University of Liverpool, along with an MSc in Physics from the University of Karlsruhe

Frank Fisher

Simon Kukec

Meet the smart, hard-working, dedicated team at Adalvo

Paulo Rodriguez is the VP of Business Development (Europe) at Adalvo, overseeing highly regulated markets, coordinating out-licensing strategies, commercial execution in the EU, and managing brand and specialty product coordination. He also drives initiatives for Business Development and partnering deals with MMC players.

With over eight years of experience in international market analysis, Paulo has gained significant expertise in implementing pharmaceutical operational models across diverse regions.

He started his career in FAES FARMA’s international department, where he managed business plans for LATAM subsidiaries (B2C) and led sales strategies and B2B activities in Europe and Asia. He later joined INTAS Pharmaceuticals, leading Business Development in CEE, Russia, and CIS regions.

Paulo holds a degree in Human Biology and an MBA in pharmaceutical and biotechnological industries from ESAME Pharmaceutical Business School.

Paulo Rodriguez

Marta Puig is responsible for the business development activities in Southern Europe.

Marta started her professional career as a consultant, but she soon joined the pharmaceutical industry, where she has over 8 years of experience in business development, commercial and sales strategies and partnership collaborations.

Prior to Adalvo, Marta worked at Galenicum Health, where she contributed to the B2C growth of the company in LATAM and the B2B expansion within Europe and APAC countries.

Marta holds a Degree in Business Administration and a MsC in International Magament at ESADE Business School, in Barcelona.

Marta Puig

Camila Reinoso is responsible for business development initiatives in Latin American countries (excluding Brazil).

Trained as a lawyer, she embarked on her professional journey in a prestigious regional law firm before making a decisive transition into the pharmaceutical sector. With a decade of experience in the pharmaceutical industry, Camila's expertise encompasses corporate advisory, pharmaceutical company acquisitions, share restructuring, and the development of diverse business models tailored to pharmaceutical product commercialization and business expansion.

Before joining Adalvo, Camila dedicated ten years to Megalabs HQ in Latin America. In her last three years, she held a pivotal role in the Business Development department, overseeing operations across more than 20 countries in the region.

Her special viewpoint, combining legal expertise and a deep understanding of the pharmaceutical field in the region, allows her to handle the complexities of Latin American markets, where Adalvo is strategically focusing and expanding steadily.

Camila Reinoso

Maria Hernando

Aida Vila

Bruno Alves is responsible for Adalvo´s business development activities in Brazil and MENA.

Bruno has over 10 years of experience in pharmaceutical business development and partnership management. 

 Before Adalvo, Bruno worked at Tecnimede´s international out-license department, where he supported the expansion of the company in MENA and APAC, with a strong knowledge of local/regional registration requirements. Bruno was responsible for forecasting and business plan analysis for both Generics and RX Innovative/Added Value products under B2B and B2C models.

Bruno holds a Master's in Biology at Faculdade de Ciências da Universidade de Lisboa.

Bruno Alves

Marc Nolasco is responsible for the business development activities in Western European countries.

Marc has over 7 years’ experience in the fields of business development, partnership collaborations, and sales strategy, with a significant portion of that time -over 4 years- spent in the pharmaceutical industry.

Prior to Adalvo, Marc worked at Galenicum Health, Chemo and Amazon Web Services, contributing to the expansion of all these companies’ B2B footprint across Europe.

Marc holds an MBA in International Management from ICEX/CECO and UIMP University in Madrid.

Marc Nolasco

Tarun serves as the Business Development Director at Aztiq's portfolio companies, including Adalvo, Alvotech, and Arphio. With extensive experience in global markets such as the US, EU, LATAM, MENA, and APAC, Tarun has successfully driven numerous In- & Out-licensing, B2B deals for Biosimilars, Peptides, Vaccines, and more. He has a proven track record in establishing Biologics CDMO & CMO businesses and identifying new opportunities to expand portfolios.

Tarun's expertise spans Global Business Development & Licensing, M&A, brand acquisition, market access strategy, and lifecycle management. He has been instrumental in pioneering biosimilar product development and achieving successful launches in the Indian market. Holding a Ph.D. in Molecular Toxicology and a Post-Doctorate in Drug Repurposing, Tarun is also a registered Pharmacist in India.

Tarun Chawla

Veronika is responsible for out-licensing Adalvo's pipeline and portfolio products, aligning strategies with our B2B objectives. Her role focuses on building expertise in differentiated generics, negotiating licensing and supply agreements, and fostering strong partnerships to expand our customer base.

Veronika brings over 8 years of international experience in pharmaceutical business development, particularly in the B2B out-licensing sector. Her expertise spans customer management, negotiations, and CRM system implementation within dynamic and fast-paced environments.